CNC2

About Actipulse Neuroscience

Actipulse Neuroscience is a clinical-stage neurotech company developing novel non-invasive brain stimulation devices for central nervous system disorders. Backed by Y Combinator and operating as a Paris Brain Institute company, it leverages a proprietary platform of high-frequency magnetic pulse technology. Its lead program for Major Depressive Disorder is in Phase 3, with a preclinical pipeline targeting oncology and other CNS conditions. The company aims to become the gold standard in neuromodulation within five years.

Therapeutic Areas

Other Central Nervous System Condition Drugs